北京招聘

1.根据标准操作规程，负责生产过程中原材料，中间产品以及终产品的质量检验
1. According to standard operating procedures, is responsible for the production of raw materials, intermediate products and final product quality inspection

2. 按照公司文件管理规定，负责对检验结果进行汇总，分析，并出具检验报告
2. According to the regulations of the company file management, responsible for the inspection result summary, analysis, and issue inspection report

3.当产品质量出现偏差时向QC和QA负责人进行汇报
3. When there is deviation of product quality report to QC and QA head

4.按照仪器使用管理规定，负责实验室仪器的常规维护和保养
4. According to the regulations of the instrument to use management, be responsible for lab equipment routine maintenance and maintenance

5. 参与与质量检验相关的文件的修订与更新
5. Participates in the revision of documents related to the quality inspection and update

6. 完成质量部主管安排的临时性任务
6. Complete temporary tasks arranged by the competent

Qualification：

1. 生物技术、生物工程、细胞生物学，免疫学相关专业本科或以上学历
1. The biological technology, biological engineering, cell biology, immunology related bachelor degree or above

2. 掌握基本的生物学实验室操作技术，有流式细胞仪操作经验者为佳。
2. Mastering the basic biology laboratory operation technology, with flow cytometry instrument operation experience is preferred.


3. 能适应灵活的工作安排
3. Able to adapt to flexible working arrangements

4. 良好的沟通与团队协作能力
4. Good communication and team cooperation ability

优先考虑：
Priority:

1. 具有流式细胞仪的操作，以及与仪器相配套的软件的使用相关经验
1. With flow cytometry instrument operation, and instrument matching software using relevant experience

2. 具有DC，T细胞以及B细胞的体外原代培养及检测的相关经验
2. With DC, T cells and B cells in vitro primary culture and testing experience

3. 具有活细胞表面抗原标记及检测的相关经验
3. A living cell surface antigen labeling and testing experience

4. 良好的英语水平
4. Good English level

5. 有1~3年生物技术公司的工作经验，应届毕业生有实验室流式细胞仪操作经验者为佳。
5. 1 ~ 3 years of work experience in a biotechnology company, new graduates have laboratory flow cytometry instrument operation experience is preferred.

舒迪安是一家跨国的生物技术公司，致力于开发基于活化树突状细胞的新治疗方法，主要专注癌症和自体免疫性疾病的治疗。我们的使命是采用基于我们自有知识产权的细胞技术并通过我们自有的免疫疗法平台来开发新的治疗产品，为目前人类未得到满足的医疗需求提供世界前沿的拓展治疗手段。一大批世界知名科学家聚集在舒迪安公司总部位于布拉格的研究中心，他们借助于目前最尖端的实验设备积极探索树突状细胞在免疫反应活化治疗中的应用。

舒迪安公司通过下列方式开发最新治疗方法：
采用自体细胞免疫疗法治疗癌症和自体免疫疾病
采用免疫疗法配合化疗等其他标准治疗方式提高临床疗效
研究免疫疗法的长期治疗效果以增强免疫系统对特定疾病的反应能力
使用广谱的肿瘤抗原，通过患者自身树突状细胞的活化，来刺激复杂的免疫反应

舒迪安公司的临床开发方案旨在采用活化树突状细胞免疫疗法，其自体细胞肿瘤免疫治疗产品为某些特定的、现有治疗手段匮乏的部分疾病拓展治疗选择。舒迪安在欧洲和中国北京建设了GMP标准细胞实验室，所生产的基于细胞的医疗产品均符合全球监管标准。

针对不同的癌症（前列腺癌、肺癌、卵巢癌等），舒迪安公司正在开展基于成熟树突状细胞负载免疫原性死亡肿瘤细胞技术的肿瘤免疫疗法的临床应用。多个单病种癌症的临床试验结果验证了舒迪安产品的临床安全性和有效性，显示出了令人振奋的临床治疗效果。

公司地址：北京亦庄经济开发区科创14街汇龙森科技园30号楼B座
市内办公室: 北京朝阳区亮马桥路50号燕莎写字楼C214

Company Introduction
SOTIO is a European biotechnology company developing new therapies based on activated dendritic cells, focusing on the treatment of cancer and autoimmune diseases. Our mission is to develop new medical therapies using our proprietary cell-based technologies to treat highly unmet medical conditions using our immunotherapy platform. Sotio (Beijing), a fast growing subsidiary focusing on China market, is looking for talented, motivated, dynamic employees to join its international team. The company can provide tremendous career development opportunity to its employees.

SOTIO is an Equal Employment Opportunity/Affirmative Action Employer
The policy and practice of SOTIO require that entry into employment and progression within employment will be determined only by personal merit and the application of criteria which are related to the duties of each particular job. Subject to statutory provisions, no applicant or member of staff will be treated less favorably than another because of his or her gender, marital or civil partnership status, sexual orientation, religion or belief, racial group, age or disability. In all cases, ability to perform the job will be the primary consideration.